A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

Clinical trial NCT00361504 · COMPLETED

Trial details

NCT number: NCT00361504
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Hip Osteoarthritis, Knee Lower Back Pain Pain

Start date: 2006-11-01
Primary completion: 2008-07-01
Enrollment: 1123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.